KCT0001581招募中未知
A Prospective, Observational, Open-label, Multi-center, Follow-up Clinical Study to Determine Recurrence of Cervical Intraepithelial Neoplasia and Evaluate the Long-term Safety of GX-188E, a DNA-based Therapeutic Vaccine, Administered Intramuscularly by Electroporation (EP) in Subjects Who Were Diagnosed with HPV 16 or 18 Positive Cervical Intraepithelial Neoplasia 3 (CIN 3) and Participated in Phase 2 Trial (GX-188E_CIN3_P2)
Gegexine0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 19(Year) 至 50(Year)（—）
- 性别
- Female
入选标准
- •1) Those who voluntarily signed informed consent form
- •2) The subjects who have participated in phase II trial(GX-188E_CIN3_P2)
排除标准
- •1) The subjects who didn't receive GX-188E DNA vaccine during phase II trial
- •2) The subject, it is difficult to participate in this study continuosly
- •3) Any other ineligible condition at the discretion of the investigator that would be ineligible to participate the study
研究者
相似试验
已完成
不适用
An Open-label, Observational, Prospective, Multicenter Study to Evaluate the LOng-teRm Efficacy and SafeTy of PerAmpanel as Monotherapy in SuBjects Age 4 Years and Older with FocaL Onset Seizures:PORTABLE StudyPatients diagnosed with Focal Onset SeizuresJPRN-UMIN000044131International University of Health and Welfare and Eisai Co., Ltd60
招募中
3 期
A clinical study to assess efficacy and safety of Febuxostat ER Tablet versus Febuxostat IR TabletCTRI/2024/01/061844AKUMS DRUGS PHARMACEUTICALS LTD
已完成
不适用
A safety study of Neucrylate AN™ Liquid Embolic System for the treatment of cerebral berry aneurysmsISRCTN36582296Valor Medical Inc. (USA)40
暂停
3 期
A clinical study to evaluate the efficacy and safety of immunoglobulin intravenous (human) 10% (NewGam) in Primary Immune Thrombocytopenia, Is the condition of having an abnormally low platelet count (thrombocytopenia) of no known cause.CTRI/2011/11/002098OCTAPHARMA AG95
已完成
2 期
A clinical study to evaluate efficacy and safety of Seven Different Topical Formulations in Subjects Suffering from Osteoarthritis of Knee(s)CTRI/2012/05/002672Emami Limited210